clinigen group plc (CLIN:London)
Ian James Nicholson B.Sc., MBA
Chief Executive Officer and Executive Director, F2G Ltd
|Age||Total Calculated Compensation||This person is connected to 24 board members in 4 different organizations across 8 different industries.|
See Board Relationships
Mr. Ian James Nicholson, B.Sc., MBA has been Chief Business Officer at NeRRe Therapeutics Ltd. since March 2014. Mr. Nicholson has been the Chief Executive Officer of F2G Ltd. since March 2013. Mr. Nicholson has been an Operating Partner at Advent Venture Partners since December 17, 2012. He is Operating Partner of London-based Advent Life Sciences LLP. He is employed as a part of the life sciences team. He served as the Chief Executive Officer of Chroma Therapeutics ...
Pitcairn HousePhone: 44 12 8349 5010
Burton-on-Trent, Staffordshire DE14 2WW
Fax: 44 12 8349 5011
Board Members Memberships*
Former Chief Executive Officer and Director
Non-Executive Director, Chairman of Corporate Responsibility (CR) Committee, Member of Remuneration Committee, Member of Nomination Committee and Member of Audit Committee
Non-Executive Director, Chairman of Remuneration Committee, Member of Audit Committee and Member of Nomination Committee
Chief Executive Officer and Executive Director
University College London
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|